PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Ann: Type D Response Submitted and Received by the US FDA, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 624 Posts.
    lightbulb Created with Sketch. 258
    LJSM, a deal has never hinged on 2x2 weekly dosing getting approved, it is something that has recently been introduced by the fanboys to try to explain why a deal has not happened.
    The management told us, they were holding off on accepting any partnership offers until after the 008 readout. Well here we are!!!!
    It is all nonsense and we are being fed nothing but B.S. from the managements mouthpieces.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.